Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Neoplasms 3Keratosis, Actinic 3Carcinoma, Basal Cell 3Skin Neoplasms 2Glioblastoma 2Carcinoma, Squamous Cell 2Urinary Bladder Neoplasms 1Lymphoma, Non-Hodgkin 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Depression 1Carcinoma, Non-Small-Cell Lung 1Anxiety Disorders 1

Interventions

HhAntag691 14Biopsy 8Imiquimod 7Aminolevulinic Acid 7sonidegib 6Tomography, Optical Coherence 6Surgical Procedures, Operative 6Photochemotherapy 6Mohs Surgery 61-phenyl-3,3-dimethyltriazene 6Radiotherapy 5Itraconazole 5Nivolumab 4Microscopy, Confocal 4Curettage 4pembrolizumab 3methyl 5-aminolevulinate 3cemiplimab 3Standard of Care 3Niacinamide 3tazarotene 2relatlimab 2X-Rays 2Watchful Waiting 2Specimen Handling 2Observation 2Magnetic Resonance Spectroscopy 2Laser Therapy 2Gene Expression Profiling 2Eflornithine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Basal Cell × Niacinamide × Clear all
NCT07286318 2026-06-05

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

University of Pittsburgh

Phase EARLY_PHASE1 Recruiting
20 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

NCT05955924 2025-02-21

SPRINTR

Women's College Hospital

Phase 3 Recruiting
396 enrolled
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT03769285 2023-04-06

SPRINTR-Pilot

Women's College Hospital

Phase 2 Unknown
120 enrolled
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡